News

Copyright © 2017, The Oklahoma Publishing Co. Oklahoma City’s Moleculera Labs Inc., an autoimmune neurobiology company, said Monday that a key patent has been issued covering the company’s method of identifying whether someone’s neurologic or psychiatric symptoms could be caused by an autoimmune dysfunction. The patent covers Moleculera’s methods of diagnosing pediatric acute-onset neuropsychiatric syndromeRead more

By Jim Stafford Copyright © 2017, The Oklahoma Publishing Co. In his second book, “Biotechnology Entrepreneurship: Starting, Managing and Leading Biotech Companies,” Craig Shimasaki, Ph.D., titles one section “Learning from Failure.” “Failure is not a person or way of life; failure is an event,” Shimasaki said. “Interestingly, you learn immeasurably more from things that don’tRead more

For OU graduate student Amanda Curtis, the 2016 BIO show required some unique multi-tasking skills. Curtis greeted visitors to the Oklahoma exhibition booth, participated in Oklahoma Bioscience networking events and sat in on multiple partnering meetings with her colleagues from OU’s Office of Technology Development. All in a day’s work.

Increasing evidence points to a relationship between certain bacterial infections and autoimmune attacks that can disrupt normal neurologic functioning, according to researchers at Moleculera Labs.

Moleculera Labs Inc. has received renewal of Commission on Office Laboratories Accreditation certification.

Moleculera provides personalized clinical testing services using the Cunningham Panel to help physicians diagnose children thought to be suffering from neurologic conditions.

When OU professor Madeleine Cunningham was a child growing up in Mississippi, her father drove her through the Southern forests and explained his work as a botanist and forestry expert.

The SeedStep Angels investing group provides sophisticated deal flow for investors, critical capital for Oklahoma entrepreneurs.

Oklahoma’s exhibition booth at the BIO convention drew premier placement because of OKBio’s work and reputation, said Tom Kupiec.

Moleculera Labs won the overall award at The Journal Record’s Innovator of the Year event honoring business innovation Thursday night.

i2E funding helps Oklahoma companies like Moleculera become successful with critical capital early in their business lifecycle.

Dr. Craig Shimasaki, entrepreneur and advisor to multiple GovCup teams, says vision begins with the way we look at the world.

Serial entrepreneur Dr. Craig Shimasaki has shared his knowledge and experience in a book and with multiple Donald W. Reynolds Governor’s Cup teams.

The StartOK Accelerator Fund, managed by i2E, Inc., recently made a $270,000 investment in Oklahoma City-based Moleculera Labs.